When a doctor opened a plug-in

Tedanis is not a person who likes to attend meetings.

He felt that researchers just needed to communicate with their peers, not with those capitalists.

Of course!

The capitalists need to coax, after all, it is the father of the gold master, the ATM machine needs to ask for money from them regularly.

Therefore, for such academic conferences held by bosses, he just smiled and refused.

Then come back and throw him in the trash can.

John smiled and said, "Perhaps we can touch the opportunity, what do you think?"

Taidanis nodded: "Okay!"

He now has no previous glory.

Everything must come from the beginning.

Sometimes, when you start again, you are not afraid of not having money or skills, but because you don’t have the humble heart you once had.

Taidanis adjusted his mentality one day, from a person who is confident of hitting the Nobel Prize to a new start, all this is by no means that simple.

He took the ticket seriously, opened it with a smile, and put it to his mouth: "I smell hope!"

...

...

Chen Cang got off the plane, and Yotel from Nature magazine came to pick him up.

When Chen Cang informed Yotel that he hoped to recruit people and attract investment.

Yotel invited Chen Cang to attend this conference in New York.

At this conference, there were many investors, many engineers from pharmaceutical companies, and many researchers and laboratories looking for investors.

These meetings are like a small venture capital market.

It's just that these investments are scientific research investments, and the purchases are all hope.

However, these companies are not stupid. In fact, they are more not investing, but acquiring patents.

After all, it is much cheaper to train a group of people to invest in R&D than to buy directly, and even these laboratories have outsourced functions.

For example, Pfizer is doing well in oncology drugs. There are some small problems that it wants to develop, but there is no relevant team. The investment in training is too large and the cycle is too long. At this time, he will not choose to cooperate with Johnson & Johnson and Roche. Will outsource small problems.

In fact, many small laboratories are mainly profitable in this way.

Therefore, it is not an exaggeration to say that foreign scientific research institutions are blooming everywhere.

Of course, for those star projects, these companies are rich and can invest, let you study them.

For example, at that time, Howard's X-pri technology of Aix was favored by Johnson & Johnson, and directly exchanged shares and invested.

Chen Cang is here today, and his purpose is very simple, to ask for money!

but!

He didn't want to sell Parkinson's technology so early, he came to sell another technology.

New stereotactic technology!

Chen Cang is short of money now. There is nothing he can do. Now Wanhe Group has just started, and the plant and equipment assembly lines are all spending money.

There is also a four-legged gold swallowing beast in the UK who is developing cardio cardioplegia, which is also costly.

just now!

Chen Cang, the scientific research laboratory here, also thought about cooperating with the Chinese Academy of Sciences, the Ministry of Science and Technology, and the Health Commission.

But after thinking about it for a long time, Chen Cang refused!

After all, as long as you ask for money from others.

You are destined to accept the management of others.

This is the policy!

Therefore, instead of doing this, it is better to find a way to make money yourself.

He didn't want to sell his shares to capitalists.

Don't want to transfer Parkinson's technology yet.

After much deliberation, the most suitable one is the "new stereotactic instrument" that I have won.

In addition, there is one more!

That is the guide production of Google’s microscope stereo imaging technology only by itself.

During this time, Bruce, the chief engineer of Google, and Walter, the chief engineer, also came to New York to meet.

This time Chen Cang was about these two things.

See how much it can sell!

It's best to pack it and sell it.

In fact, Chen Cang is more inclined to complete the acquisition by Google.

Because he knows that Google has such capabilities.

Moreover, microscopic imaging technology and new stereotactic instruments can be combined.

Once combined, the effect will be more significant!

Why didn't Chen Cang sell it to China?

Very simple...

The price is not high!

Chen Cang is not doing public welfare.

He also wants to buy a good price.

On the same day, the editor-in-chief of "Nature" Yotel took Chen Cang to the hotel for a little rest, and then arrived at the venue.

Chen Cang didn't have much time to delay.

The week-long appointment has reached the sixth day!

Tomorrow, Chen Cang will return home with a huge sum of money.

His price is 500 million US dollars!

With the 500 million dollars in hand, he believes that the construction of the laboratory should not be a big problem?

The meeting hasn't started yet, but there are already many people in the huge venue.

Yortel's arrival attracted a lot of attention.

After all, he is the editor-in-chief of Nature, and his status is still very high.

However, when Yotel introduced Chen Cang to everyone, he immediately attracted everyone's attention in the room.

"Chen Cang! Professor Chen?"

"That surgical genius?"

"No, he is a scientific research wizard now!"

"Yes, I read that paper. It makes sense. Professor Chen Cang has a better understanding of Parkinson than everyone, including Professor Tydanis!"

"It turned out to be Professor Chen! Why did he come?"

"Is it... for patents?"

For a time!

When Chen Cang appeared at the conference, more and more people began to call the company.

As an international city in New York, many large pharmaceutical groups have subsidiaries here.

After learning that Chen Cang was present at the venue, he immediately dispatched the branch manager to arrive here, and be sure to keep in touch with the head office at any time.

This time, Chen Cang's research on Parkinson's has attracted the attention of these large pharmaceutical companies.

In the eyes of everyone, Chen Cang is simply a tempting sweet pastry!

In the afternoon, when Tedanis and John arrived at the venue with related research results, they were suddenly taken aback.

Taidanis was someone who had seen the big scene, but...even so, he was a little surprised.

Why are there so many bosses in this venue?

Most of the giants of New York Pharmaceutical Company came, and the general manager level came in person.

This scene shocked Tedanis a bit!

Why on earth?

what happened?

However, he soon learned the reason.

Because he saw a familiar figure in the crowd: Chen Cang!

After seeing it, Taidanis' heart is full of mixed flavors.

I used to be aloof and even wanted to calculate Chen Cang and get the results of his research on Parkinson.

now……

Such a meeting.

Chen Cang has become the existence of Zhongxing Pengyue, but he... Few people care about it.

In the eyes of capital, he is no longer the first person in Parkinson's field.

Thinking of this, if Tedanis said he didn't regret it, it would definitely be a lie.

If there is a chance to turn back, he will never refuse!